Home » Newsletters » BioWorld Science

BioWorld Science

June 22, 2021

View Archived Issues

Enrollment opens in phase I study of DCC-3116 in advanced solid tumors with RAS or RAF mutations

First-in-human study of ChAdOx1 RVF vaccine candidate begins at University of Oxford

Origo Biopharma patents TGFBR1 inhibitors

BioNTech initiates first-in-human study of BNT-152 and BNT-153 in solid tumors

Medshine Discovery discloses Chk1 inhibitors for pancreatic cancer

New GTPase KRAS mutant inhibitors presented by Taiho Pharmaceutical

Lunan Pharmaceutical Group describes oleanane cinnamamide derivatives

European researchers identify CaSR-targeting antibodies

City of Hope National Medical Center presents FIH data on COH04S1 vaccine

Promising data reported from CYAD-211 IMMUNICY-1 trial

Initial phase I data on Betalutin in relapsed/refractory DLBCL

Phase II trial of Auxora in patients with acute pancreatitis and accompanying SIRS and hypoxemia

Stimulation of optic nerve activity increases optic glioma growth in mice with Nf1 mutations

Results from first-in-human study of AO-176 in advanced solid tumors

STING inhibitors target inflammatory diseases

Anti-COX-2 Ab is a novel highly specific diagnostic marker in immune aplastic anemia

Sanofi Pasteur and Translate Bio begin phase I trial of mRNA seasonal influenza vaccine

Dicerna begins phase II study of belcesiran for AAT deficiency-associated liver disease

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...